Skip to main content
SpringerLink
Log in

Percutaneous Approach to Transitional Cell Carcinoma of the Upper Urinary Tract

  • Chapter
Endourological Management of Urogenital Carcinoma

Part of the book series: Recent Advances in Endourology ((ENDOUROLOGY,volume 7))

  • 388 Accesses

Summary

The preliminary rationale for endoscopic management of upper tract transitional cell carcinoma (UTTCC) was to preserve renal parenchyma and to decrease the morbidity of therapy. In this regard, endoscopic management was introduced to treat patients with UTTCC in an anatomic or functional solitary kidney, patients with bilateral disease, and patients who were not candidates for open surgery due to underlying comorbidity. Today, endoscopic management remains the standard of care for such patients, as long as they have noninvasive disease. A percutaneous approach, in particular, has proven to be an effective minimally invasive treatment for large (>1.5 cm), low-grade UTTCC limited to the calices, renal pelvis, and proximal ureter. Because of the high incidence of recurrence and progression, elective endourologic management for grade III T1 tumors is not recommended. Some controversy still exists regarding the use of endoscopic management in patients with a normal contralateral kidney, in those who have multiple tumors in the same kidney or ipsilateral collecting system, and in patients with a solitary kidney with high-grade disease. This chapter describes the technique and discusses results of recent studies on percutaneous management of UTTCC. Recent results of instillation immuno- and chemotherapy for upper tract urothelial carcinoma are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kimball FN, Ferris HW (1934) Papillomatous tumor of the renal pelvis associated with similar tumors of the ureter and bladder: review of the literature and report of two cases. J Urol 31:257–259

    Google Scholar 

  2. Huffman JL, Bagley DH, Lyon ES, Morse MJ, Herr HW, Whitmore WFJ (1985) Endoscopic diagnosis and treatment of upper tract urothelial tumors. A preliminary report. Cancer 55:1422–1428

    CAS  PubMed  Google Scholar 

  3. Streem SB, Pontes EJ (1986) Percutaneous management of upper tract transitional cell carcinoma. J Urol 135:773–775

    CAS  PubMed  Google Scholar 

  4. Smith AD, Orihuela E, Crowley AR (1987) Percutaneous management of renal pelvic tumors: treatment option in selected cases. J Urol 137:852–856

    CAS  PubMed  Google Scholar 

  5. Herr HW (1985) Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J Urol 134:531–532

    CAS  PubMed  Google Scholar 

  6. Powder JR, Mosberg WH, Pierpoint RZ (1984) Bilateral primary carcinoma of the ureter: topical and: ureteral thiotepa. J Urol 132:349–352

    CAS  PubMed  Google Scholar 

  7. Clayman RV, Kavoussi LR, Figenshau RS, Chandhoke PS, Albala DM (1991) Laparoscopic nephroureterectomy: initial clinical case report. J Laparoendosc Surg 1(6):343–349

    CAS  PubMed  Google Scholar 

  8. Clayman RV, McDougall EM, Nakada SY (1998) Endourology of the upper urinary tract: percutaneous renal and ureteral procedures. In:Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology, vol. 3. Saunders, Philadelphia, pp 2831–2836

    Google Scholar 

  9. Jarrett TW, Sweetser PM, Weiss GH, Smith AD (1995) Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol 154:1629–1635

    CAS  PubMed  Google Scholar 

  10. Wishnow KI, Johnson DE, Preston D, Tenney D (1990) Long-term serum creatinine values after radical nephrectomy. Urology 35:114–116

    Article  CAS  PubMed  Google Scholar 

  11. Clark PE, Streem SB, Geisinger MA (1999) 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 161:772–776

    Article  CAS  PubMed  Google Scholar 

  12. Durek C, Rusch-Gerdes S, Jocham D, Bohle A (2000) Sensitivity of BCG to modern antibiotics. Eur Urol 37:21–25

    Article  CAS  PubMed  Google Scholar 

  13. Jabbour ME, Desgrandchamps F, Cazin S, Teillac P, Le Duc A, Smith AD (2000) Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 163:1105–1107

    Article  CAS  PubMed  Google Scholar 

  14. Liatsikos EN, Dinlenc CZ, Kapoor R, Smith AD (2001) Transitional-cell carcinoma of the Renal Pelvis: Ureteroscopic and percutaneous approach. J Endourol 15(4):377–383

    Article  CAS  PubMed  Google Scholar 

  15. Elliot DS, Segura JW, Lightner D, Patterson DE, Blute ML (2001) Is nephroureterectomy necessary in all cases of upper tract transitional carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 58:174–178

    Google Scholar 

  16. Palou J, Piovesan LF, Huguet J, Salvador J, Vincente J, Villavicencio H (2004) Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol 172:66–69

    PubMed  Google Scholar 

  17. Goel MC, Mahendra V, Roberts JG (2003) Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 169:925–930

    Article  PubMed  Google Scholar 

  18. Patel A, Soonawalla P, Shepherd SF, Dearnaley DP, Kellett MJ, Woodhouse CRJ (1996) Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 155:868–874

    CAS  PubMed  Google Scholar 

  19. Plancke HR, Strijbos WE, Delaere KP (1995) Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br J Urol 75:736–739

    CAS  PubMed  Google Scholar 

  20. Lee BR, Jabbour ME, Marshall FF, Smith AD, Jarrett TW (1999) 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: Equivalent outcomes. J Endourol 13:289–294

    CAS  PubMed  Google Scholar 

  21. Martinez-Pineiro JA, Matres Garcia MJ, Martinez-Pineiro L (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 156:377–385

    CAS  PubMed  Google Scholar 

  22. Jabbour ME, Smith AD (2000) Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am 27:739–750

    Article  CAS  PubMed  Google Scholar 

  23. Sharma NK, Nicol A, Powell CS (1994) Tract infiltration following percutaneous resection of renal pelvic transitional cell carcinoma. Br J Urol 73:597–598

    CAS  PubMed  Google Scholar 

  24. Huang A, Low RK, White R (1995) Case reports: Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J Urol 153:1041–1042

    CAS  PubMed  Google Scholar 

  25. Oefelein MG, MacLennan G (2003) Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. J Urol 170:521

    PubMed  Google Scholar 

  26. Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172:1271–1275

    Article  CAS  PubMed  Google Scholar 

  27. Mills IW, Laniado ME, Patel A (2001) The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma. BJU Int 87:150–162

    Article  CAS  PubMed  Google Scholar 

  28. Chen GL, El-Gabry EA, Bagley DH (2000) Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol 165:1901–1904

    Google Scholar 

  29. Keeley FX, Bibbo M, Bagley DH (1997) Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157:1560–1565

    Article  PubMed  Google Scholar 

  30. Herr HW (1985) Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. J Urol 134:531–532

    CAS  PubMed  Google Scholar 

  31. Patel A, Fuchs GJ (1998) New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J Urol 159:71–75

    Article  CAS  PubMed  Google Scholar 

  32. Studer UE, Casanova G, Kraft R, Zingg EJ (1989) Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. J Urol 142:975–977

    CAS  PubMed  Google Scholar 

  33. Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S (2002) Intravesical instillation of bacillus Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract utilizing vesicoureteral reflux created by a double-pigtail catheter. Urology 59:53–57

    Article  PubMed  Google Scholar 

  34. Sharpe JR, Duffy G, Chin JL (1993) Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol 149:457–460

    CAS  PubMed  Google Scholar 

  35. Yokogi H, Wada Y, Mizutani M, Igawa M, Ishibe T (1996) Bacillus Calmette Guerin perfusion therapy for carcinoma in situ of the upper urinary tract. Br J Urol 77:676–679

    CAS  PubMed  Google Scholar 

  36. Nishino Y, Yamammoto N, Komeda H, Takahashi Y, Deguchi T (2000) Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int 85:799–801

    Article  CAS  PubMed  Google Scholar 

  37. Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K, Takaha N, Takahara S, Okuyama A (2000) Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol 38:701–705

    Article  CAS  PubMed  Google Scholar 

  38. Okubo K, Ichioka K, Terada N, Matsuta Y, Arai YK (2001) Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure. BJU Int 88:343–347

    Article  CAS  PubMed  Google Scholar 

  39. Thalmann GN, Markwalder R, Walter B, Studer UE (2002) Long term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 168:1381–1385

    Article  PubMed  Google Scholar 

  40. Marcovich R, Jacobson A, Smith A (2004). Percutaneous upper tract-preserving approaches in urothelial cancer. In: Droller MJ (ed) Treatment of upper tract urothelial cancer: American Cancer Society atlas of clinical oncology—urothelial tumors. Decker, Hamilton, pp 340–352

    Google Scholar 

  41. Schoenberg MP, Van Arsdalen KN, Wein AJ (1991) The management of transitional cell carcinoma in solitary renal units. J Urol 1991; 146:700–703

    CAS  PubMed  Google Scholar 

  42. Bellman GC, Sweetser P, Smith D (1994) Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol 151:13–15

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Long Island Jewish Medical Center, New Hyde Park, NY, 11040-1496, USA

    Beng Jit Tan, Michael C. Ost, Benjamin R. Lee & Arthur D. Smith

  2. Division of Urology, University of Texas Health Science Center, San Antonio, TX, USA

    Robert Marcovich

Authors
  1. Beng Jit Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael C. Ost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Marcovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benjamin R. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arthur D. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Seiji Naito M.D., Ph.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Urology, Nara Medical University, 840 Shijyocho, Kashihara, Nara, 634-8522, Japan

    Yoshihiko Hirao M.D., Ph.D. (Professor and Chairman) (Professor and Chairman)

  3. Surgical Science Urology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa, 259-1193, Japan

    Toshiro Terachi M.D., Ph.D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 The Japanese Society of Endourology and ESWL

About this chapter

Cite this chapter

Tan, B.J., Ost, M.C., Marcovich, R., Lee, B.R., Smith, A.D. (2006). Percutaneous Approach to Transitional Cell Carcinoma of the Upper Urinary Tract. In: Naito, S., Hirao, Y., Terachi, T. (eds) Endourological Management of Urogenital Carcinoma. Recent Advances in Endourology, vol 7. Springer, Tokyo. https://doi.org/10.1007/4-431-27786-2_3

Download citation

  • DOI: https://doi.org/10.1007/4-431-27786-2_3

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-27785-9

  • Online ISBN: 978-4-431-27786-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation